Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Phenotype of Platelet Is Altered and Associated with Disease Activity of Rheumatoid Arthritis

Hidekata Yasuoka, MD PhD, Keiko Yoshimoto, PhD, Komei Sakata, MD, Mihoko Kato, Mako Koseki, Kotaro Matsumoto, MD, Hiroshi Takei, MD, Tsutomu Takeuchi, MD PhD

Blood (2017) 130 (Supplement 1): 3609.

https://doi.org/10.1182/blood.V130.Suppl_1.3609.3609

Published: 2017

Journal Articles

A Phase 2 Dose-Confirmation Study of Oral ASTX727, a Combination of Oral Decitabine with a Cytidine Deaminase Inhibitor (CDAi) Cedazuridine (E7727), in Subjects with Myelodysplastic Syndromes (MDS)

Guillermo Garcia-Manero, MD, Elizabeth A. Griffiths, MD, Gail J. Roboz, MD, Lambert Busque, MD, Richard A. Wells, MD DPhil, Olatoyosi Odenike, MD, David P. Steensma, MD, Karen W.L. Yee, MD, Stefan Faderl, Philip C. Amrein, MD, Laura C. Michaelis, MD, Hagop M. Kantarjian, MD, Aram Oganesian, James N. Lowder, MD, Mohammad Azab, MD, Michael R. Savona, MD

Blood (2017) 130 (Supplement 1): 4274.

https://doi.org/10.1182/blood.V130.Suppl_1.4274.4274

Published: 2017

Journal Articles

Successful Emulation of IV Decitabine Pharmacokinetics with an Oral Fixed-Dose Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine, in Subjects with Myelodysplastic Syndromes (MDS): Final Data of Phase 1 Study

Guillermo Garcia-Manero, MD, Olatoyosi Odenike, MD, Philip C. Amrein, MD, David P. Steensma, MD, Amy E. DeZern, MD MHS, Laura C. Michaelis, MD, Stefan Faderl, MD, Hagop M. Kantarjian, MD, James N. Lowder, MD, Pietro Taverna, PhD, Aram Oganesian, PhD, Xiaoping Zhang, PhD, Mohammad Azab, MD, Michael R. Savona, MD

Blood (2016) 128 (22): 114.

https://doi.org/10.1182/blood.V128.22.114.114

Published: 2016

Journal Articles

Congenital Dyserythropoietic Anemias: Molecular Diagnosis and Diagnostic Approach in a Cohort of Italian Patients

Veronica Agrigento, Sclafani Serena, Paolo Rigano, Rita Barone, Giuseppina Calvaruso, Rosario Di Maggio, Massimiliano Sacco, Lorella Pitrolo, Angela Vitrano, Aurelio Maggio, Elena D'Alcamo

Blood (2015) 126 (23): 2142.

https://doi.org/10.1182/blood.V126.23.2142.2142

Published: 2015

Journal Articles

Results of First in Human (FIH) Phase 1 Pharmacokinetic (PK) Guided Dose-Escalation Study of ASTX727, a Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine in Subjects with Myelodysplastic Syndromes (MDS)

Michael R. Savona, MD, Olatoyosi Odenike, MD, Philip C. Amrein, MD, David P. Steensma, MD, Wael A. Harb, MD, Amy E. DeZern, MD MHS, Laura C. Michaelis, MD, Stefan Faderl, MD, James N. Lowder, MD, Pietro Taverna, PhD, Aram Oganesian, PhD, Richa Dua, PharmD, Roya Nawabi, Mohammad Azab, MD, Guillermo Garcia-Manero, MD

Blood (2015) 126 (23): 1683.

https://doi.org/10.1182/blood.V126.23.1683.1683

Published: 2015

Journal Articles

Preclinical Data In Cynomolgus (cyn) Monkeys Of ASTX727, a Novel Oral Hypomethylating Agent (HMA) Composed Of Low-Dose Oral Decitabine Combined With a Novel Cytidine Deaminase Inhibitor (CDAi) E7727

Aram Oganesian, PhD, Sanjeev Redkar, PhD, Pietro Taverna, PhD, Rajashree Joshi-Hangal, PhD, Mohammad Azab, MD

Blood (2013) 122 (21): 2526.

https://doi.org/10.1182/blood.V122.21.2526.2526

Published: 2013

Journal Articles

Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up

Richard K. Burt, Robert M. Craig, Francesca Milanetti, Kathleen Quigley, Paula Gozdziak, Jurate Bucha, Alessandro Testori, Amy Halverson, Larissa Verda, Willem J. S. de Villiers, Borko Jovanovic, Yu Oyama

Blood (2010) 116 (26): 6123–6132.

https://doi.org/10.1182/blood-2010-06-292391

Published: 2010

Journal Articles

Intrafistular Injection of AUTOLOGOUS BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS for the TREATMENT of Refractory Perianal CROHN'S DISEASE.

Maria Ester Bernardo, Rachele Ciccocioppo, Maria Antonietta Avanzini, Adele Sgarella, MD, Maria Luisa Russo, MD, Cristina Ubezio, Biologist, Federico Bonetti, Mara Scabini, Costanza Alvisi, MD, Ombretta Luinetti, Cesare Perotti, MD, Rita Maccario, Laura Salvaneschi, MD, Fabrizio Calliada, Paolo Dionigi, Gino Roberto Corazza, Franco Locatelli

Blood (2009) 114 (22): 2676.

https://doi.org/10.1182/blood.V114.22.2676.2676

Published: 2009

Journal Articles

Novel Evidence That Very Small Embryonic Like Stem Cells (VSELs) Are Mobilized Into Peripheral Blood in Patients with Inflammatory Bowel Diseases – Correlation with Young Age and Severity of Disease.

Wojciech Marlicz, MD, PhD, Edyta Paczkowska, MD, PhD, Maciek Halasa, MD, PhD, Boguslaw Machaliñski, MD, PhD, Teresa Starzynska, MD, PhD, Mariusz Z Ratajczak, MD, PhD

Blood (2009) 114 (22): 4595.

https://doi.org/10.1182/blood.V114.22.4595.4595

Published: 2009

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation for Crohn’s Diseases - 5 Cases Report.

Jian Ouyang, MD, Longdian Chen, MD, Bing Chen, MD, Jingyan Xu, Cuiping Li, De Pei Wu, MD

Blood (2006) 108 (11): 5437.

https://doi.org/10.1182/blood.V108.11.5437.5437

Published: 2006

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation for Refractory Crohn’s Disease, the Summary of Phase I Trial.

Yu Oyama, MD, Robert Craig, MD, Ann Traynor, MD, Laivyde Statkute, MD, Richard Burt, MD

Blood (2005) 106 (11): 2919.

https://doi.org/10.1182/blood.V106.11.2919.2919

Published: 2005

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation in Patients with Severe and Refractory Crohn’s Disease.

Yu Oyama, MD, Robert M. Craig, MD, Ann E. Traynor, MD, Richard K. Burt, MD, Laisvyde Statkute, MD

Blood (2004) 104 (11): 1874.

https://doi.org/10.1182/blood.V104.11.1874.1874

Published: 2004

Journal Articles

High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease

Richard K. Burt, Ann Traynor, Yu Oyama, Robert Craig

Blood (2003) 101 (5): 2064–2066.

https://doi.org/10.1182/blood-2002-07-2122

Published: 2003

NARROW

Phenotype of Platelet Is Altered and Associated with Disease Activity of Rheumatoid Arthritis

A Phase 2 Dose-Confirmation Study of Oral ASTX727, a Combination of Oral Decitabine with a Cytidine Deaminase Inhibitor (CDAi) Cedazuridine (E7727), in Subjects with Myelodysplastic Syndromes (MDS)

Successful Emulation of IV Decitabine Pharmacokinetics with an Oral Fixed-Dose Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine, in Subjects with Myelodysplastic Syndromes (MDS): Final Data of Phase 1 Study

Congenital Dyserythropoietic Anemias: Molecular Diagnosis and Diagnostic Approach in a Cohort of Italian Patients

Results of First in Human (FIH) Phase 1 Pharmacokinetic (PK) Guided Dose-Escalation Study of ASTX727, a Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine in Subjects with Myelodysplastic Syndromes (MDS)

Preclinical Data In Cynomolgus (cyn) Monkeys Of ASTX727, a Novel Oral Hypomethylating Agent (HMA) Composed Of Low-Dose Oral Decitabine Combined With a Novel Cytidine Deaminase Inhibitor (CDAi) E7727

Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up

Intrafistular Injection of AUTOLOGOUS BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS for the TREATMENT of Refractory Perianal CROHN'S DISEASE.

Novel Evidence That Very Small Embryonic Like Stem Cells (VSELs) Are Mobilized Into Peripheral Blood in Patients with Inflammatory Bowel Diseases – Correlation with Young Age and Severity of Disease.

Autologous Hematopoietic Stem Cell Transplantation for Crohn’s Diseases - 5 Cases Report.

Autologous Hematopoietic Stem Cell Transplantation for Refractory Crohn’s Disease, the Summary of Phase I Trial.

Autologous Hematopoietic Stem Cell Transplantation in Patients with Severe and Refractory Crohn’s Disease.

High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only